These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 28556562)
1. Drug Release as a function of bioactivity, incubation regime, liquid, and initial load: Release of bortezomib from calcium phosphate-containing silica/collagen xerogels. Kruppke B; Hose D; Schnettler R; Seckinger A; Rößler S; Hanke T; Heinemann S J Biomed Mater Res B Appl Biomater; 2018 Apr; 106(3):1165-1173. PubMed ID: 28556562 [TBL] [Abstract][Full Text] [Related]
2. Calcium phosphate phases integrated in silica/collagen nanocomposite xerogels enhance the bioactivity and ultimately manipulate the osteoblast/osteoclast ratio in a human co-culture model. Heinemann S; Heinemann C; Wenisch S; Alt V; Worch H; Hanke T Acta Biomater; 2013 Jan; 9(1):4878-88. PubMed ID: 23072829 [TBL] [Abstract][Full Text] [Related]
3. Effect of Washing Treatment on the Textural Properties and Bioactivity of Silica/Chitosan/TCP Xerogels for Bone Regeneration. Pérez-Moreno A; Reyes-Peces MV; Vilches-Pérez JI; Fernández-Montesinos R; Pinaglia-Tobaruela G; Salido M; de la Rosa-Fox N; Piñero M Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361087 [TBL] [Abstract][Full Text] [Related]
4. In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials. Radin S; Falaize S; Lee MH; Ducheyne P Biomaterials; 2002 Aug; 23(15):3113-22. PubMed ID: 12102182 [TBL] [Abstract][Full Text] [Related]
5. Bioactive silica-collagen composite xerogels modified by calcium phosphate phases with adjustable mechanical properties for bone replacement. Heinemann S; Heinemann C; Bernhardt R; Reinstorf A; Nies B; Meyer M; Worch H; Hanke T Acta Biomater; 2009 Jul; 5(6):1979-90. PubMed ID: 19345651 [TBL] [Abstract][Full Text] [Related]
6. Sol-gel processing of anti-inflammatory entrapment in silica, release kinetics, and bioactivity. Catauro M; Melisi D; Curcio A; Rimoli MG J Biomed Mater Res A; 2008 Dec; 87(4):843-9. PubMed ID: 18200553 [TBL] [Abstract][Full Text] [Related]
7. Manipulation of osteoclastogenesis: Bioactive multiphasic silica/collagen composites and their effects of surface and degradation products. Rößler S; Heinemann C; Kruppke B; Wagner AS; Wenisch S; Wiesmann HP; Hanke T Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():265-276. PubMed ID: 30274058 [TBL] [Abstract][Full Text] [Related]
8. Calcite incorporated in silica/collagen xerogels mediates calcium release and enhances osteoblast proliferation and differentiation. Rößler S; Unbehau R; Gemming T; Kruppke B; Wiesmann HP; Hanke T Sci Rep; 2020 Jan; 10(1):118. PubMed ID: 31924823 [TBL] [Abstract][Full Text] [Related]
9. The in vitro and in vivo indomethacin release from self-setting bioactive glass bone cement. Otsuka M; Nakahigashi Y; Matsuda Y; Kokubo T; Yoshihara S; Fujita H; Nakamura T Biomed Mater Eng; 1997; 7(5):291-302. PubMed ID: 9457380 [TBL] [Abstract][Full Text] [Related]
10. A novel skeletal drug delivery system using self-setting calcium phosphate cement. 7. Effect of biological factors on indomethacin release from the cement loaded on bovine bone. Otsuka M; Nakahigashi Y; Matsuda Y; Fox JL; Higuchi WI J Pharm Sci; 1994 Nov; 83(11):1569-73. PubMed ID: 7891276 [TBL] [Abstract][Full Text] [Related]
11. Bioactive silica-based drug delivery systems containing doxorubicin hydrochloride: in vitro studies. Prokopowicz M; Zegliński J; Gandhi A; Sawicki W; Tofail SA Colloids Surf B Biointerfaces; 2012 May; 93():249-59. PubMed ID: 22325320 [TBL] [Abstract][Full Text] [Related]
12. In vitro bioactivity and structural features of mildly heat-treated sol-gel-derived silica fibers. Peltola T; Jokinen M; Veittola S; Simola J; Yli-Urpo A J Biomed Mater Res; 2001 Mar; 54(4):579-90. PubMed ID: 11426604 [TBL] [Abstract][Full Text] [Related]
13. In vitro release of cisplatin from sol-gel processed organically modified silica xerogels. Czarnobaj K; Lukasiak J J Mater Sci Mater Med; 2007 Oct; 18(10):2041-4. PubMed ID: 17558477 [TBL] [Abstract][Full Text] [Related]
14. Correlation between physicochemical properties of doxorubicin-loaded silica/polydimethylsiloxane xerogel and in vitro release of drug. Prokopowicz M Acta Biomater; 2009 Jan; 5(1):193-207. PubMed ID: 18755642 [TBL] [Abstract][Full Text] [Related]
15. Bioactive silica-based nanomaterials for doxorubicin delivery: evaluation of structural properties associated with release rate. Prokopowicz M Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):3942-50. PubMed ID: 23910300 [TBL] [Abstract][Full Text] [Related]
16. Surface modification of P(EMA-co-HEA)/SiO2 nanohybrids for faster hydroxyapatite deposition in simulated body fluid? Vallés Lluch A; Ferrer GG; Pradas MM Colloids Surf B Biointerfaces; 2009 May; 70(2):218-25. PubMed ID: 19185471 [TBL] [Abstract][Full Text] [Related]
17. Surface-Activated Fibre-Like SBA-15 as Drug Carriers for Bone Diseases. Prokopowicz M; Żeglinski J; Szewczyk A; Skwira A; Walker G AAPS PharmSciTech; 2018 Dec; 20(1):17. PubMed ID: 30574669 [TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds. Margiotta N; Ostuni R; Teoli D; Morpurgo M; Realdon N; Palazzo B; Natile G Dalton Trans; 2007 Aug; (29):3131-9. PubMed ID: 17637988 [TBL] [Abstract][Full Text] [Related]
19. In Vitro Release Kinetics and Transferrin Saturation Study of Intravenous Iron Sucrose Entrapped in Poly(ethylene glycol)-Assisted Silica Xerogel. Jha J; Chakraborty S; Chaudhuri MG; Dey R Appl Biochem Biotechnol; 2016 Apr; 178(7):1351-62. PubMed ID: 26686338 [TBL] [Abstract][Full Text] [Related]
20. In vitro tobramycin elution analysis from a novel beta-tricalcium phosphate-silicate-xerogel biodegradable drug-delivery system. DiCicco M; Goldfinger A; Guirand F; Abdullah A; Jansen SA J Biomed Mater Res B Appl Biomater; 2004 Jul; 70(1):1-20. PubMed ID: 15199578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]